- Home
- BPMC vs BRFS Comparison
BPMC vs BRFS Comparison
Compare BPMC & BRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- BRFS
- Stock Information
- Founded
- BPMC 2008
- BRFS 1934
- Country
- BPMC United States
- BRFS Brazil
- Employees
- BPMC N/A
- BRFS N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- BRFS Meat/Poultry/Fish
- Sector
- BPMC Health Care
- BRFS Consumer Staples
- Exchange
- BPMC Nasdaq
- BRFS Nasdaq
- Market Cap
- BPMC 5.8B
- BRFS 5.5B
- IPO Year
- BPMC 2015
- BRFS 2000
- Fundamental
- Price
- BPMC $99.18
- BRFS $3.46
- Analyst Decision
- BPMC Buy
- BRFS Buy
- Analyst Count
- BPMC 21
- BRFS 2
- Target Price
- BPMC $124.05
- BRFS $14.50
- AVG Volume (30 Days)
- BPMC 1.0M
- BRFS 2.3M
- Earning Date
- BPMC 05-01-2025
- BRFS 05-16-2025
- Dividend Yield
- BPMC N/A
- BRFS 2.79%
- EPS Growth
- BPMC N/A
- BRFS N/A
- EPS
- BPMC N/A
- BRFS 0.31
- Revenue
- BPMC $562,121,000.00
- BRFS $9,924,014,641.00
- Revenue This Year
- BPMC $44.85
- BRFS $11.16
- Revenue Next Year
- BPMC $32.06
- BRFS $4.20
- P/E Ratio
- BPMC N/A
- BRFS $10.97
- Revenue Growth
- BPMC 99.19
- BRFS 14.48
- 52 Week Low
- BPMC $73.04
- BRFS $2.99
- 52 Week High
- BPMC $121.90
- BRFS $4.87
- Technical
- Relative Strength Index (RSI)
- BPMC 65.95
- BRFS 44.14
- Support Level
- BPMC $97.91
- BRFS $3.45
- Resistance Level
- BPMC $104.86
- BRFS $3.67
- Average True Range (ATR)
- BPMC 3.74
- BRFS 0.11
- MACD
- BPMC 1.50
- BRFS -0.05
- Stochastic Oscillator
- BPMC 83.26
- BRFS 6.45
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About BRFS BRF S.A.
BRF SA is an international producer of fresh and frozen protein foods. It operates by raising, producing, and slaughtering poultry and pork for processing, production, and sale of fresh meat, processed products, pasta, margarine, pet food, and others. The Company holds as its main brands Sadia, Perdigao, Qualy, Chester, Kidelli, Perdix, Banvit, Biofresh, and Gran Plus, present mainly in Brazil, Turkey, and Middle Eastern countries. The group has three reportable segments, being; Brazil, International, and Other segments.